Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116317274 | 11631727 | 4 | F | 20150224 | 20151015 | 20160802 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK015071 | GLENMARK | ALVAREZ M V, GROGAN P M, ALVAREZ M. A TALE OF TWO RESTLESS SISTERS. 17TH INTERNATIONAL CONGRESS OF PARKINSON^S DISEASE AND MOVEMENT DISORDERS. 2013;28:S229 | 71.00 | YR | F | Y | 0.00000 | 20160802 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116317274 | 11631727 | 1 | PS | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | UNK | U | 90781 | ||||||||||
116317274 | 11631727 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | UNK | U | 0 | ||||||||||
116317274 | 11631727 | 3 | C | RASAGILINE | RASAGILINE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116317274 | 11631727 | 1 | Restless legs syndrome |
116317274 | 11631727 | 2 | Restless legs syndrome |
116317274 | 11631727 | 3 | Restless legs syndrome |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116317274 | 11631727 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |